Name
Orident Hambakliinik OÜ
Registry code
12369093
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
26.10.2012 (12)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
86231 - Provision of dental treatment 47741 - Retail sale of medical and orthopaedic goods in specialised stores
699 651 €
67 480 €
10%
2 135 €
(estimate is approximate)
173 582 €
10
Submitted
No tax arrears
39%
30%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Marina Roiland 15.11.1961 (63) | 51% - 1 304.00 EUR | Board member | Direct ownership | |
| Kätlin Raja 15.06.1980 (44) | 49% - 1 252.00 EUR | Board member | Direct ownership | |
| Kaja Rattiste 27.07.1974 (50) | - | - | - | Founder |
| 2019 27.08.2020 | 2020 12.07.2021 | 2021 21.06.2022 | 2022 03.07.2023 | 2023 27.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 384 049 € | 414 866 € | 513 996 € | 550 591 € | 699 651 € |
| Net profit (loss) for the period | 37 978 € | 25 959 € | 41 366 € | 30 067 € | 67 480 € |
| Profit Margin | 10% | 6% | 8% | 5% | 10% |
| Current Assets | 58 422 € | 79 154 € | 109 568 € | 138 769 € | 185 938 € |
| Fixed Assets | 98 374 € | 94 150 € | 77 316 € | 53 693 € | 37 007 € |
| Total Assets | 156 796 € | 173 304 € | 186 884 € | 192 462 € | 222 945 € |
| Current Liabilities | 40 866 € | 38 615 € | 44 029 € | 42 360 € | 49 363 € |
| Non Current Liabilities | 21 220 € | 14 020 € | 6 820 € | 0 € | - |
| Total Liabilities | 62 086 € | 52 635 € | 50 849 € | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 94 710 € | 120 669 € | 136 035 € | 150 102 € | 173 582 € |
| Employees | 9 | 10 | 10 | 10 | 10 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 32 379.9 € | 34 779.63 € | 12 |
| 2023 Q4 | - | 34 607.14 € | 37 233.97 € | 14 |
| 2023 Q3 | - | 36 967.93 € | 33 425.92 € | 14 |
| 2023 Q2 | - | 32 919.35 € | 31 291.53 € | 11 |
| 2023 Q1 | - | 25 945.66 € | 27 997.02 € | 12 |
| 2022 Q4 | - | 26 506.15 € | 28 500.61 € | 14 |
| 2022 Q3 | - | 25 544.96 € | 27 514.3 € | 13 |
| 2022 Q2 | - | 29 485.92 € | 28 279.09 € | 14 |
| 2022 Q1 | - | 25 932.58 € | 28 034.72 € | 14 |
| 2021 Q4 | - | 25 282.87 € | 27 349.08 € | 14 |
| 2021 Q3 | - | 27 145.59 € | 25 169.28 € | 14 |
| 2021 Q2 | - | 26 622.9 € | 26 282.68 € | 15 |
| 2021 Q1 | - | 19 221.84 € | 20 998.02 € | 15 |
| 2020 Q4 | - | 22 173.57 € | 24 151.33 € | 15 |
| 2020 Q3 | - | 19 521.82 € | 21 151.57 € | 16 |
| 2020 Q2 | - | 11 558.82 € | 12 498.67 € | 16 |
| 2020 Q1 | - | 21 153.36 € | 22 846.56 € | 15 |
